. Author manuscript; available in PMC: 2021 Mar 8.

Published in final edited form as: Anal Chim Acta. 2019 Dec 19;1101:90–98. doi: 10.1016/j.aca.2019.12.033

Table 1.

Characteristics of PDX PDAC tumors and cells.

Tumor	Tumorigenicity	Invasiveness	Clinical Stage^*	KRAS status^†	Codon mutation details^‡
					Codon mutation details^‡
	Time to growth^a	Metastatic rate^b			G12	G12	G12
T608	2.0 months	100%	met	mut	aa12(G➔D)	None	None
T366	2.8 months	75%	met	mut	aa12(G➔D)	None	None
T395	4.5 months	40%	pri	mut	aa12(G➔L)	NT	NT
T449	2.0 months	0%	pri	mut	aa12(G➔D)	NT	NT
T188	6.0 months	100%	pri	wt	None	NT	NT
T738	7.2 months	25%	pri	wt	None	None	None

- in mouse model

– in abdominal or liver

met - metastatic; pri – primary

^†

mut - mutant; wt - wild-type.

^‡

NT - not tested.